Aerie Pharmaceuticals to Present at the Canaccord Genuity Growth Conference

DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, today announced that Richard Rubino, Chief Financial Officer, will present in a fireside chat discussion at the Canaccord Genuity Growth Conference on Thursday, August 9, 2018 at 1:30 p.m. Eastern